<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2678328-A1" country="EP" doc-number="2678328" kind="A1" date="20140101" family-id="45592409" file-reference-id="315082" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146551167" ucid="EP-2678328-A1"><document-id><country>EP</country><doc-number>2678328</doc-number><kind>A1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12703835-A" is-representative="NO"><document-id mxw-id="PAPP154825090" load-source="docdb" format="epo"><country>EP</country><doc-number>12703835</doc-number><kind>A</kind><date>20120216</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220438325" load-source="docdb" format="original"><country>EP</country><doc-number>12703835.4</doc-number><date>20120216</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140453027" ucid="EP-11155155-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>11155155</doc-number><kind>A</kind><date>20110221</date></document-id></priority-claim><priority-claim mxw-id="PPC140454144" ucid="EP-12703835-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>12703835</doc-number><kind>A</kind><date>20120216</date></document-id></priority-claim><priority-claim mxw-id="PPC140448171" ucid="EP-2012052644-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>2012052644</doc-number><kind>W</kind><date>20120216</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988098762" load-source="docdb">A01N  43/12        20060101ALI20120910BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988117857" load-source="docdb">C07D 333/80        20060101AFI20120910BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988127486" load-source="docdb">C07D 409/12        20060101ALI20120910BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL2007295788" load-source="docdb" scheme="CPC">A01N  43/36        20130101 LI20140201BHEP        </classification-cpc><classification-cpc mxw-id="PCL2007295791" load-source="docdb" scheme="CPC">A01N  43/12        20130101 LI20140123BHEP        </classification-cpc><classification-cpc mxw-id="PCL2007295792" load-source="docdb" scheme="CPC">A01N  43/56        20130101 FI20140201BHEP        </classification-cpc><classification-cpc mxw-id="PCL2109743023" load-source="docdb" scheme="CPC">C07D 333/80        20130101 LI20140903BHEP        </classification-cpc><classification-cpc mxw-id="PCL2109743186" load-source="docdb" scheme="CPC">C07D 409/12        20130101 LI20140903BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132185985" lang="DE" load-source="patent-office">NEUE CARBOXAMID-MIKROBIOZIDE</invention-title><invention-title mxw-id="PT132185986" lang="EN" load-source="patent-office">NOVEL CARBOXAMIDE MICROBIOCIDES</invention-title><invention-title mxw-id="PT132185987" lang="FR" load-source="patent-office">NOUVEAUX MICROBIOCIDES CARBOXAMIDE</invention-title><citations><non-patent-citations><nplcit><text>See references of WO 2012113696A1</text><sources><source mxw-id="PNPL67451852" load-source="docdb" name="SEA"/></sources></nplcit></non-patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR918148292" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SYNGENTA PARTICIPATIONS AG</last-name><address><country>CH</country></address></addressbook></applicant><applicant mxw-id="PPAR918144106" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SYNGENTA PARTICIPATIONS AG</last-name></addressbook></applicant><applicant mxw-id="PPAR918984639" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Syngenta Participations AG</last-name><iid>101302295</iid><address><street>Schwarzwaldallee 215</street><city>4058 Basel</city><country>CH</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918150863" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>WALTER HARALD</last-name><address><country>CH</country></address></addressbook></inventor><inventor mxw-id="PPAR918154047" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>WALTER, HARALD</last-name></addressbook></inventor><inventor mxw-id="PPAR918981176" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>WALTER, HARALD</last-name><address><street>Syngenta Crop Protection Münchwilen AG Schaffhauserstrasse</street><city>CH-4332 Stein</city><country>CH</country></address></addressbook></inventor><inventor mxw-id="PPAR918135266" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>STIERLI DANIEL</last-name><address><country>CH</country></address></addressbook></inventor><inventor mxw-id="PPAR918139192" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>STIERLI, DANIEL</last-name></addressbook></inventor><inventor mxw-id="PPAR918981291" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>STIERLI, DANIEL</last-name><address><street>Syngenta Crop Protection Münchwilen AG Schaffhauserstrasse</street><city>CH-4332 Stein</city><country>CH</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR918980081" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Hölscher, Ingo</last-name><suffix>et al</suffix><iid>101360290</iid><address><street>Syngenta International AG Intellectual Property Schwarzwaldallee 215</street><city>4058 Basel</city><country>CH</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="EP-2012052644-W"><document-id><country>EP</country><doc-number>2012052644</doc-number><kind>W</kind><date>20120216</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012113696-A1"><document-id><country>WO</country><doc-number>2012113696</doc-number><kind>A1</kind><date>20120830</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS548924484" load-source="docdb">AL</country><country mxw-id="DS548815417" load-source="docdb">AT</country><country mxw-id="DS548924485" load-source="docdb">BE</country><country mxw-id="DS548927645" load-source="docdb">BG</country><country mxw-id="DS548836588" load-source="docdb">CH</country><country mxw-id="DS548911891" load-source="docdb">CY</country><country mxw-id="DS548815418" load-source="docdb">CZ</country><country mxw-id="DS548933532" load-source="docdb">DE</country><country mxw-id="DS548911892" load-source="docdb">DK</country><country mxw-id="DS548911893" load-source="docdb">EE</country><country mxw-id="DS548925716" load-source="docdb">ES</country><country mxw-id="DS548927646" load-source="docdb">FI</country><country mxw-id="DS548927647" load-source="docdb">FR</country><country mxw-id="DS548924490" load-source="docdb">GB</country><country mxw-id="DS548911894" load-source="docdb">GR</country><country mxw-id="DS548924491" load-source="docdb">HR</country><country mxw-id="DS548815419" load-source="docdb">HU</country><country mxw-id="DS548836589" load-source="docdb">IE</country><country mxw-id="DS548924492" load-source="docdb">IS</country><country mxw-id="DS548927648" load-source="docdb">IT</country><country mxw-id="DS548911895" load-source="docdb">LI</country><country mxw-id="DS548933533" load-source="docdb">LT</country><country mxw-id="DS548815420" load-source="docdb">LU</country><country mxw-id="DS548933534" load-source="docdb">LV</country><country mxw-id="DS548933535" load-source="docdb">MC</country><country mxw-id="DS548864706" load-source="docdb">MK</country><country mxw-id="DS548864707" load-source="docdb">MT</country><country mxw-id="DS548925717" load-source="docdb">NL</country><country mxw-id="DS548927649" load-source="docdb">NO</country><country mxw-id="DS548925722" load-source="docdb">PL</country><country mxw-id="DS548836590" load-source="docdb">PT</country><country mxw-id="DS548925723" load-source="docdb">RO</country><country mxw-id="DS548836591" load-source="docdb">RS</country><country mxw-id="DS548925724" load-source="docdb">SE</country><country mxw-id="DS548836592" load-source="docdb">SI</country><country mxw-id="DS548864708" load-source="docdb">SK</country><country mxw-id="DS548864709" load-source="docdb">SM</country><country mxw-id="DS548911896" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA99625730" ref-ucid="WO-2012113696-A1" lang="EN" load-source="patent-office"><p num="0000">Compounds of formula (I) wherein R<sub>1</sub> is C<sub>1</sub>-C<sub>4</sub>alkyl, C<sub>1</sub>-C<sub>4</sub>haloalkyl or C<sub>1</sub>-C<sub>4</sub>alkoxy; R<sub>2</sub> is C<sub>1</sub>-C<sub>4</sub>alkyl; R<sub>3</sub> is hydrogen or halogen; R<sub>4</sub> is hydrogen, C<sub>1</sub>-C<sub>4</sub>alkyl or C<sub>1</sub>-C<sub>4</sub>halogenalkyl; X is methine or nitrogen; A is R<sub>5</sub> is hydrogen, halogen, -≡-C<sub>1</sub>-C<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; R<sub>6</sub> is hydrogen, halogen, -≡-C<sub>1</sub>-C<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; and agrochemically acceptable salts/isomers/structural isomers/stereoisomers/diastereoisorners/enantiorners/tautorriers and N-oxides of those compounds are suitable for use as microbiocides.</p></abstract><abstract mxw-id="PA99824249" ref-ucid="WO-2012113696-A1" lang="EN" source="national office" load-source="docdb"><p>Compounds of formula (I) wherein R1 is C1-C4alkyl, C1-C4haloalkyl or C1-C4alkoxy; R2 is C1-C4alkyl; R3 is hydrogen or halogen; R4 is hydrogen, C1-C4alkyl or C1-C4halogenalkyl; X is methine or nitrogen; A is R5 is hydrogen, halogen, -=-C1-C6alkyl, -=-C3-C7cycloalkyl or -=-aryl; R6 is hydrogen, halogen, -=-C1-C6alkyl, -=-C3-C7cycloalkyl or -=-aryl; and agrochemically acceptable salts/isomers/structural isomers/stereoisomers/diastereoisorners/enantiorners/tautorriers and N-oxides of those compounds are suitable for use as microbiocides.</p></abstract><abstract mxw-id="PA99625731" ref-ucid="WO-2012113696-A1" lang="FR" load-source="patent-office"><p num="0000">L'invention concerne des composés de formule (I) dans laquelle R<sub>1</sub> représente un alkyle en C<sub>1</sub>-C<sub>4</sub>, un halogénoalkyle en C<sub>1</sub>-C<sub>4</sub> ou un alcoxy en C<sub>1</sub>-C<sub>4</sub> ; R<sub>2</sub> représente un alkyle en C<sub>1</sub>-C<sub>4</sub> ; R<sub>3</sub> représente l'hydrogène ou un halogène ; R<sub>4</sub> représente l'hydrogène, un alkyle en C<sub>1</sub>-C<sub>4</sub> ou un halogénoalkyle en C<sub>1</sub>-C<sub>4</sub> ; X représente le méthine ou l'azote ; A représente R<sub>5</sub> qui représente l'hydrogène, un halogène, -≡-alkyle en C<sub>1</sub>-C<sub>6</sub>, -≡-cycloalkyle en C<sub>3</sub>-C<sub>7</sub> ou -≡-aryle ; R<sub>6</sub> représente l'hydrogène, un halogène, -≡-alkyle en C<sub>1</sub>-C<sub>6</sub>, -≡-cycloalkyle en C<sub>3</sub>-C<sub>7</sub> ou -≡-aryle ; et les sels/isomères/isomères structuraux/stéréoisomères/diastéréoisomères/énantiomères/tautomères et N-oxydes agrochimiquement acceptables de ces composés qui sont appropriés pour être utilisés en tant que microbiocides.</p></abstract><abstract mxw-id="PA99824250" ref-ucid="WO-2012113696-A1" lang="FR" source="national office" load-source="docdb"><p>L'invention concerne des composés de formule (I) dans laquelle R1 représente un alkyle en C1-C4, un halogénoalkyle en C1-C4 ou un alcoxy en C1-C4 ; R2 représente un alkyle en C1-C4 ; R3 représente l'hydrogène ou un halogène ; R4 représente l'hydrogène, un alkyle en C1-C4 ou un halogénoalkyle en C1-C4 ; X représente le méthine ou l'azote ; A représente R5 qui représente l'hydrogène, un halogène, -=-alkyle en C1-C6, -=-cycloalkyle en C3-C7 ou -=-aryle ; R6 représente l'hydrogène, un halogène, -=-alkyle en C1-C6, -=-cycloalkyle en C3-C7 ou -=-aryle ; et les sels/isomères/isomères structuraux/stéréoisomères/diastéréoisomères/énantiomères/tautomères et N-oxydes agrochimiquement acceptables de ces composés qui sont appropriés pour être utilisés en tant que microbiocides.</p></abstract><description mxw-id="PDES50931373" ref-ucid="WO-2012113696-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="2"/>--><p id="p0001" num="0001"> NOVEL CARBOXAMIDE MICROBIOCIDES </p><p id="p0002" num="0002">The present invention relates to novel microbiocidally active, in particular fungicidally active, carboxamides. It further relates to intermediates used in the preparation of these </p><p id="p0003" num="0003">compounds, to compositions which comprise these compounds and to their use in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi. </p><p id="p0004" num="0004">Fungicidally active N-substituted-N-bicyclic carboxamides are described, for example, in WO 2009/016218 and WO 2010/130767. It has been found that novel carboxamides with a specific substitution pattern have microbiocidal activity. </p><p id="p0005" num="0005">The present invention accordingly relates to N-alkoxycarboxamides of formula I </p><p id="p0006" num="0006"><img id="imgf000002_0001" he="32" wi="71" file="imgf000002_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0007" num="0007">wherein </p><p id="p0008" num="0008"> Ri is CrC<sub>4</sub>alkyl, C C<sub>4</sub>haloalkyl or C C<sub>4</sub>alkoxy; </p><p id="p0009" num="0009"> R<sub>2</sub> is CrC<sub>4</sub>alkyl; </p><p id="p0010" num="0010"> R<sub>3</sub> is hydrogen or halogen; </p><p id="p0011" num="0011"> R<sub>4</sub> is hydrogen, C C<sub>4</sub>alkyl or C C<sub>4</sub>halogenalkyl; </p><p id="p0012" num="0012"> X is methine or nitrogen; </p><p id="p0013" num="0013"> A is </p><p id="p0014" num="0014"><img id="imgf000002_0002" he="38" wi="80" file="imgf000002_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0015" num="0015">R<sub>5</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; </p><p id="p0016" num="0016">R<sub>6</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; 
<!-- EPO <DP n="3"/>-->
 and agrochemically acceptable salts/isomers/structural </p><p id="p0017" num="0017">isomers/stereoisomers/diastereoisomers/enantiomers/tautomers and N-oxides of those compounds. </p><p id="p0018" num="0018">The alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, /<sup>'</sup>so-propyl, n-butyl, sec-butyl, /<sup>'</sup>so-butyl or te/f-butyl. Alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned. Halogen is generally fluorine, chlorine, bromine or iodine, preferably fluorine, bromine or chlorine. This also applies, correspondingly, to halogen in combination with other meanings, such as halogenalkyi or halogenalkoxy. Haloalkyl groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 , 1-difluoro-2,2,2- trichloroethyl, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert- butoxy; preferably methoxy and ethoxy. Halogenalkoxy is, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2- fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy and 2,2,2-trichloroethoxy; preferably difluoromethoxy, 2-chloroethoxy and trifluoromethoxy. Cycloalkyl is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl. </p><p id="p0019" num="0019">Aryl in the definition of substituents R<sub>5</sub> and R<sub>6</sub> is preferably phenyl, benzyl or naphthyl, or phenyl, benzyl or naphthyl mono-, di- or trisubstituted by halogen, cyano, nitro, halogen, C C<sub>6</sub>alkyl, C<sub>2</sub>-C<sub>6</sub>alkenyl, C<sub>2</sub>-C<sub>6</sub>alkynyl, C<sub>3</sub>-C<sub>6</sub>cycloalkyl, CrC<sub>6</sub>haloalkyl, C<sub>2</sub>-C<sub>6</sub>haloalkenyl, C<sub>2</sub>- C<sub>6</sub>haloalkynyl, C<sub>3</sub>-C<sub>6</sub>halocycloalkyl, C C<sub>4</sub>alkoxy, C C<sub>4</sub>haloalkoxy, C C<sub>4</sub>alkylthio, C </p><p id="p0020" num="0020">C<sub>4</sub>haloalkylthio, CrC<sub>4</sub>alkylsulfinyl, CrC<sub>4</sub>alkylsulfonyl, C C<sub>4</sub>alkylamino, C<sub>2</sub>-C<sub>4</sub>dialkylamino, C<sub>3</sub>-C<sub>6</sub>cycloalkylamino, Ci-C<sub>6</sub>alkyl-C3-C<sub>6</sub>cycloalkylamino, C<sub>2</sub>-C<sub>4</sub>alkylcarbonyl, C<sub>2</sub>- C<sub>6</sub>alkoxycarbonyl, C<sub>2</sub>-C<sub>6</sub>alkylaminocarbonyl, C<sub>3</sub>-C<sub>6</sub>dialkylaminocarbonyl, C<sub>2</sub>- C<sub>6</sub>alkoxycarbonyloxy, C<sub>2</sub>-C<sub>6</sub>alkylaminocarbonyloxy, C<sub>3</sub>-C<sub>6</sub>dialkylaminocarbonyloxy or C<sub>3</sub>- C<sub>6</sub>trialkylsilyl. </p><p id="p0021" num="0021">In preferred compounds of formula I, independently from each other, </p><p id="p0022" num="0022">a) R is difluoromethyl, trifluoromethyl or methyl; </p><p id="p0023" num="0023">b) R<sub>2</sub> is methyl; </p><p id="p0024" num="0024">c) R<sub>3</sub> is hydrogen; 
<!-- EPO <DP n="4"/>-->
 d) R<sub>4</sub> is hydrogen, methyl or ethyl; </p><p id="p0025" num="0025">e) R<sub>5</sub> is hydrogen or halogen; and </p><p id="p0026" num="0026">f) R<sub>6</sub> is hydrogen or halogen. In a preferred group of compounds of formula I, </p><p id="p0027" num="0027"> is difluoromethyl or trifluoromethyl; </p><p id="p0028" num="0028">R<sub>2</sub> is methyl; </p><p id="p0029" num="0029">R<sub>3</sub> is hydrogen; and </p><p id="p0030" num="0030">R<sub>4</sub> is methyl. </p><p id="p0031" num="0031">Further compounds of formula I are preferred, wherein </p><p id="p0032" num="0032">Ri is CrC<sub>4</sub>haloalkyl; </p><p id="p0033" num="0033">R<sub>2</sub> is Ci-C<sub>4</sub>alkyl; </p><p id="p0034" num="0034">R<sub>3</sub> is hydrogen; </p><p id="p0035" num="0035">R<sub>4</sub> is C C<sub>4</sub>alkyl; </p><p id="p0036" num="0036"> R<sub>5</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl or -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl; </p><p id="p0037" num="0037">X is methine or nitrogen; and </p><p id="p0038" num="0038">In an especially preferred group of compounds of formula I, </p><p id="p0039" num="0039"> Ri is Ci-C<sub>4</sub>haloalkyl; </p><p id="p0040" num="0040">R<sub>2</sub> is Ci-C<sub>4</sub>alkyl; </p><p id="p0041" num="0041">R<sub>3</sub> is hydrogen; </p><p id="p0042" num="0042">R<sub>4</sub> is Ci-C<sub>4</sub>alkyl; </p><p id="p0043" num="0043">R<sub>6</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl or -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl; </p><p id="p0044" num="0044"> X is methine or nitrogen; and </p><p id="p0045" num="0045">A is A<sub>2</sub>. </p><p id="p0046" num="0046">Compounds of formula I may be prepared by reacting a compound of formula II </p><p id="p0047" num="0047">H-N A (II), </p><p id="p0048" num="0048">wherein A is as defined under formula I; with a compound of formula III 
<!-- EPO <DP n="5"/>-->
</p><p id="p0049" num="0049"><img id="imgf000005_0001" he="36" wi="31" file="imgf000005_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="yes"/></p><p id="p0050" num="0050">in which R<sub>2</sub> and R<sub>3</sub> are as defined under formula I, and R* is halogen, hydroxy or </p><p id="p0051" num="0051">Ci-6 alkoxy, preferably chloro. Compounds of formula III are known and described, for example, in US 5,093,347 and WO 2008/148570 or can be prepared by methods known <sup>'</sup> the art. For example, the compo </p><p id="p0052" num="0052"><img id="imgf000005_0002" he="37" wi="50" file="imgf000005_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0053" num="0053">wherein R<sub>9</sub> is d-C<sub>6</sub>alkyl, can be prepared by reacting a compound of formula Illb 
<img id="imgf000005_0003" he="21" wi="50" file="imgf000005_0003.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0054" num="0054">wherein R<sub>9</sub> is as defined for formula Ilia and R<sub>10</sub> is CrC<sub>6</sub>alkyl, with methylhydrazine in the presence of water, a hydroxide base and an organic solvent selected from an aromatic hydrocarbon and a halogen-substituted aromatic hydrocarbon. </p><p id="p0055" num="0055">The reactions for the preparation of compounds of formula I are advantageously carried out in aprotic inert organic solvents. Such solvents are hydrocarbons such as benzene, toluene, xylene or cyclohexane, chlorinated hydrocarbons such as dichloromethane, </p><p id="p0056" num="0056">trichloromethane, tetrachloromethane or chlorobenzene, ethers such as diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, tetrahydrofuran or dioxane, nitriles such as acetonitrile or propionitrile, amides such as N,N-dimethylformamide, diethylformamide or N-methylpyrrolidinone. The reaction temperatures are advantageously between -20°C and +120°C. In general, the reactions are slightly exothermic and, as a rule, they can be carried out at ambient temperature. To shorten the reaction time, or else to start the reaction, the mixture may be heated briefly to the boiling point of the reaction mixture. The reaction times can also be shortened by adding a few drops of base as reaction catalyst. Suitable bases are, in particular, tertiary amines such as trimethylamine, triethylamine, 
<!-- EPO <DP n="6"/>-->
 quinuclidine, 1 ,4-diazabicyclo[2.2.2]octane, 1 ,5-diazabicyclo[4.3.0]non-5-ene or </p><p id="p0057" num="0057">1 ,5-diazabicyclo[5.4.0]undec-7-ene. However, inorganic bases such as hydrides, e.g. sodium hydride or calcium hydride, hydroxides, e.g. sodium hydroxide or potassium hydroxide, carbonates such as sodium carbonate and potassium carbonate, or hydrogen carbonates such as potassium hydrogen carbonate and sodium hydrogen carbonate may also be used as bases. The bases can be used as such or else with catalytic amounts of a phase-transfer catalyst, for example a crown ether, in particular 18-crown-6, or a tetraalkylammonium salt. </p><p id="p0058" num="0058">When R* is hydroxy, a coupling agent, such as benzotriazol-l-yloxytris(dimethylamino) phosphoniumhexafluorophosphate, bis-(2-oxo-3-oxazolidinyl)-phosphinic acid chloride (BOP- Cl), Ν,Ν'-dicyclohexylcarbodiimide (DCC) or 1 , 1'-carbonyl-diimidazole (CDI), may be used. </p><p id="p0059" num="0059">The intermediates of formula II 
<img id="imgf000006_0001" he="20" wi="26" file="imgf000006_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0060" num="0060">wherein A is as defined under formula I, preferably wherein R<sub>4</sub> is C C<sub>4</sub>alkyl; are novel and were developed specifically for the preparation of the compounds of the formula I. </p><p id="p0061" num="0061">Accordingly, these intermediates of the formula II also form a part of the subject-matter of the present invention. </p><p id="p0062" num="0062">The preferred substituent definitions for the compounds of formula I are also valid for the compound of formula II. </p><p id="p0063" num="0063">Scheme 1 : Synthesis of compounds of formula I (A=A<sub>1</sub>): 
<!-- EPO <DP n="7"/>-->
</p><p id="p0064" num="0064"><img id="imgf000007_0001" he="34" wi="153" file="imgf000007_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="yes"/></p><p id="p0065" num="0065">NCS or NBS or Y<sub>2</sub> (Y = CI, solvent </p><p id="p0066" num="0066"><img id="imgf000007_0002" he="40" wi="102" file="imgf000007_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0067" num="0067">The ketone 1 is known from the literature and can be prepared as described therein (e.g. Molecules, 2009, 14, 3494-3508). </p><p id="p0068" num="0068">Scheme 2: Synthesis of compounds of formula I (A=A?): 
<img id="imgf000007_0003" he="93" wi="156" file="imgf000007_0003.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 
<!-- EPO <DP n="8"/>-->
 The preparation of ketone 2 is described in literature (Bulletin de la Societe Chimique France 1970, 1 , 322-31 and Comptes Rendus des Seances de I'Academie des Sciences, Serie C: Sciences Chimique 1968, 267(2), 156-58). A synthesis sequence for ketone 2 using the known starting material 3-(3- bromopropyl)thiophene (Helv. Chim. Acta 1995, 78(7), 1887-93) is described in scheme 3. </p><p id="p0069" num="0069">Scheme 3: Synthesis of ketone 2: 
<img id="imgf000008_0001" he="22" wi="147" file="imgf000008_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0070" num="0070"> (XI) </p><p id="p0071" num="0071"> (VIII) (IX) (X) P<sub>2</sub>0<sub>5</sub>/celite toluene reflux 
<img id="imgf000008_0002" he="16" wi="16" file="imgf000008_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0072" num="0072">The compounds I and, where appropriate, the tautomers thereof, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form. </p><p id="p0073" num="0073">It has now been found that the compounds of formula I according to the invention have, for practical purposes, a very advantageous spectrum of activities for protecting useful plants against diseases that are caused by phytopathogenic microorganisams, such as fungi, bacteria or viruses. </p><p id="p0074" num="0074">The invention therefore also relates to a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a compound of formula I is applied as active ingredient to the plants, to parts thereof or the locus thereof. The compounds of formula I according to the invention are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and are used for protecting numerous useful plants. The compounds of formula I can be used to inhibit or destroy the diseases that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms. 
<!-- EPO <DP n="9"/>-->
 It is also possible to use compounds of formula I as dressing agents for the treatment of plant propagation material, in particular of seeds (fruit, tubers, grains) and plant cuttings (e.g. rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. </p><p id="p0075" num="0075">Furthermore the compounds of formula I according to the invention may be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage or in hygiene </p><p id="p0076" num="0076">management. </p><p id="p0077" num="0077">The compounds of formula I are, for example, effective against the phytopathogenic fungi of the following classes: Fungi imperfecti (e.g. Botrytis, Pyricularia, Helminthosporium, </p><p id="p0078" num="0078">Fusarium, Septoria, Cercospora and Alternaria) and Basidiomycetes (e.g. Rhizoctonia, Hemileia, Puccinia). Additionally, they are also effective against the Ascomycetes classes (e.g. Venturia and Erysiphe, Podosphaera, Monilinia, Uncinula) and of the Oomycetes classes (e.g. Phytophthora, Pythium, Plasmopara). Outstanding activity has been observed against powdery mildew (Erysiphe spp.). Furthermore, the novel compounds of formula I are effective against phytopathogenic bacteria and viruses (e.g. against Xanthomonas spp, Pseudomonas spp, Erwinia amylovora as well as against the tobacco mosaic virus). Good activity has been observed against Asian soybean rust (Phakopsora pachyrhizi). </p><p id="p0079" num="0079">Within the scope of the invention, useful plants to be protected typically comprise the following species of plants: cereal (wheat, barley, rye, oat, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, drupes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucumber plants (pumpkins, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamomum, camphor) or plants such as tobacco, nuts, coffee, eggplants, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, as well as ornamentals. </p><p id="p0080" num="0080">The term "useful plants" is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and 
<!-- EPO <DP n="10"/>-->
 trifloxysulfuron, EPSPS (5-enol-pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® , Herculex I® and LibertyLink®. The term "useful plants" is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus. Examples of such plants are: YieldGard® (maize variety that expresses a CrylA(b) toxin);</p><p id="p0081" num="0081">YieldGard Rootworm® (maize variety that expresses a CrylllB(bl) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a Cryll I B(b1 ) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin); Bollgard I® (cotton variety that expresses a CrylA(c) toxin); Bollgard II® (cotton variety that expresses a CrylA(c) and a CryllA(b) toxin); VIPCOT® (cotton variety that expresses a VIP toxin); NewLeaf® (potato variety that expresses a CrylllA toxin); NatureGard® Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait), Agrisure® RW (corn rootworm trait) and Protecta®. </p><p id="p0082" num="0082">The term "useful plants" is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. 
<!-- EPO <DP n="11"/>-->
 The term "locus" of a useful plant as used herein is intended to embrace the place on which the useful plants are growing, where the plant propagation materials of the useful plants are sown or where the plant propagation materials of the useful plants will be placed into the soil. An example for such a locus is a field, on which crop plants are growing. </p><p id="p0083" num="0083">The term "plant propagation material" is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There may be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. </p><p id="p0084" num="0084"> Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. Preferably "plant propagation material" is understood to denote seeds. </p><p id="p0085" num="0085">The compounds of formula I can be used in unmodified form or, preferably, together with carriers and adjuvants conventionally employed in the art of formulation. </p><p id="p0086" num="0086">Therefore the invention also relates to compositions for controlling and protecting against phytopathogenic microorganisms, comprising a compound of formula I and an inert carrier, and to a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a composition, comprising a compound of formula I as umiga ingredient and an inert carrier, is applied to the plants, to parts thereof or the locus thereof. To this end compounds of formula I and inert carriers are conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects. Suitable carriers and adjuvants (auxiliaries) can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, 
<!-- EPO <DP n="12"/>-->
 dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890. </p><p id="p0087" num="0087">The compounds of formula I or compositions, comprising a compound of formula I as umiga ingredient and an inert carrier, can be applied to the locus of the plant or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations which influence the growth of plants. They can also be selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation. </p><p id="p0088" num="0088">A preferred method of applying a compound of formula I, or a composition, comprising a compound of formula I as umiga ingredient and an inert carrier, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen. However, the compounds of formula I can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation. </p><p id="p0089" num="0089">A formulation, i.e. a composition comprising the compound of formula I and, if desired, a solid or liquid adjuvant, is prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface-active compounds (surfactants). </p><p id="p0090" num="0090">The agrochemical formulations will usually contain from 0.1 to 99% by weight, preferably from 0.1 to 95% by weight, of the compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5% by weight, of a solid or liquid adjuvant, and from 0 to 25% by weight, preferably from 0.1 to 25% by weight, of a surfactant. </p><p id="p0091" num="0091">Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations. 
<!-- EPO <DP n="13"/>-->
 Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i. /ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient rates of application are from 10mg to 1 g of active substance per kg of seeds. The rate of application for the desired action can be determined by experiments. It depends for example on the type of action, the developmental stage of the useful plant, and on the the application (location, timing, application method) and can, owing to these parameters, vary within wide limits. </p><p id="p0092" num="0092">The compounds of formula (I), or a pharmaceutical salt thereof, described above may also have an advantageous spectrum of activity for the treatment and/or prevention of microbial infection in an animal. "Animal" can be any animal, for example, insect, mammal, reptile, fish, amphibian, preferably mammal, most preferably human. "Treatment" means the use on an animal which has microbial infection in order to reduce or slow or stop the increase or spread of the infection, or to reduce the infection or to cure the infection. "Prevention" means the use on an animal which has no apparent signs of microbial infection in order to prevent any future infection, or to reduce or slow the increase or spread of any future infection. </p><p id="p0093" num="0093">According to the present invention there is provided the use of a compound of formula (I) in the manufacture of a medicament for use in the treatment and/or prevention of microbial infection in an animal. There is also provided the use of a compound of formula (I) as a pharmaceutical agent. There is also provided the use of a compound of formula (I) as an antimicrobial agent in the treatment of an animal. According to the present invention there is also provided a pharmaceutical composition comprising as an active ingredient a compound of formula (I), or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable umigate or carrier. This composition can be used for the treatment and/or prevention of antimicrobial infection in an animal. This pharmaceutical composition can be in a form suitable for oral administration, such as tablet, lozenges, hard capsules, aqueous suspensions, oily suspensions, emulsions dispersible powders, dispersible granules, syrups and elixirs. Alternatively this pharmaceutical composition can be in a form suitable for topical application, such as a spray, a cream or lotion. Alternatively this pharmaceutical composition can be in a form suitable for parenteral administration, for example injection. Alternatively this pharmaceutical composition can be in inhalable form, such as an aerosol spray. </p><p id="p0094" num="0094">The compounds of formula (I) may be effective against various microbial species able to cause a microbial infection in an animal. Examples of such microbial species are those causing Aspergillosis such as Aspergillus umigates, A. flavus, A. terms, A. nidulans and A. niger, those causing Blastomycosis such as Blastomyces dermatitidis; those causing</p><p id="p0095" num="0095">Candidiasis such as Candida albicans, C. Glabrata, C. Tropicalis, C. Parapsilosis, C. Krusei 
<!-- EPO <DP n="14"/>-->
 and C. Lusitaniae; those causing Coccidioidomycosis such as Coccidioides immitis; those causing Cryptococcosis such as Cryptococcus neoformans; those causing Histoplasmosis such as Histoplasma capsulatum and those causing Zygomycosis such as Absidia corymbifera, Rhizomucor pusillus and Rhizopus arrhizus. Further examples are Fusarium Spp such as Fusarium oxysporum and Fusarium solani and Scedosporium Spp such as</p><p id="p0096" num="0096">Scedosporium apiospermum and Scedosporium prolificans. Still further examples are Microsporum Spp, Trichophyton Spp, Epidermophyton Spp, Mucor Spp, Sporothorix Spp, Phialophora Spp, Cladosporium Spp, Petriellidium spp, Paracoccidioides Spp and </p><p id="p0097" num="0097">Histoplasma Spp. </p><p id="p0098" num="0098">The following non-limiting Examples illustrate the above-described invention in greater detail without limiting it. </p><p id="p0099" num="0099">Preparatory examples: </p><p id="p0100" num="0100"> Example 1 : Preparation of 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid methoxy- (5,6,7,8-tetrahydro-4H-cvclohepta[b1thiophen-8-yl)amide (Compound No. 2.35): </p><p id="p0101" num="0101">Stepl : In a sulfonation flsak a mixture consisting of 1.67g (10.05 mmol) 4,5,6,7-tetrahydro- cyclohepta[b]thiophene-8-one, 1.05g (12.56mmol) O-methylhydroxylaminehydrochlorid, 0.99g (12.56 mmol) pyridine and 37ml methanol was stirred for 20 hours at ambient temperature. The resulting solution was diluted with 500ml of ethylacetate and the organic phase was washed 3 times with water. After drying of the organic phase over sodium sulphate and distilling off the solvent in a water jet vacuum, the crude reaction product was obtained. The raw material was purified by flash chromatography over silica gel (eluent ethylacetate/heptanes 1 :6), 1.96g of (4,5,6,7-tetrahydrocyclohepta[b]thiophen-8-one)-0- methyloxime was obtained (yellowish oil). </p><p id="p0102" num="0102">Step 2: In a sulfonation flask 1.92g (9.84 mmol) of the O-methyloxime obtained from step 1 was dissolved in 30 ml of acetic acid. 1.24g (19.68 mmol) of NaCNBH<sub>3</sub> are added </p><p id="p0103" num="0103">portionwise over a period of ca. 1.5 hours. After stirring for 18 hours, further 309mg of</p><p id="p0104" num="0104">NaCNBH<sub>3</sub> was added and stirring continued for 42 hours. The resulting solution was diluted with 50ml of water and the pH was adjusted to 8 by adding 120 ml of a 4N aqueous NaOH solution. The water phase was 3 times extracted with AcOEt. The organic phase was the dried over sodium sulphate and the solvent distilled off in a water jet vacuum. The crude oil was purified by flash chromatography over silica gel (eluant: TBME/heptanes 1 :6). 1.28g of 
<!-- EPO <DP n="15"/>-->
 0-methyl-N-(5,67,8-tetrahydro-4H-cyclohepta[b]thiophen-8-yl)hydroxylamine was obtained in the form of a colourless liquid. </p><p id="p0105" num="0105">Step 3: In a sulfonation flask 0.62g (3.15 mmol) of the O-methylhydroxylamine obtained in step 2 was dissolved in 30ml of methylenechlorid and 0.48g (4.7 mmol) triethylamine and a mixture of 0.74g (3.78 mmol) 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid chloride and 10 ml was added slowly in ca. 10 minutes. The reaction mixture was stirred for 16 hours at ambient temperature. The solvent was distilled partially off and the residue directly purified by flash chromatography over silica gel (eluant: ethylacetate/heptanes 1 : 1). 0.93g of compound 2.35 was obtained as a white powder (m.p.: 130-132°C). </p><p id="p0106" num="0106">Example 2: Preparation of 3-difluoromethyl-1-methyl-1-H-pyrazole-4-carboxylic acid (2- bromo-5,6,7,8-tetrahvdro-4H-cvclohepta[b1thiophen-8-yl) methoxy amide (Compound No. 2.41): </p><p id="p0107" num="0107"> In a sulfonation flask 213 mg (0.6 mmol) of compound 2.35, 214 mg (1.2 mmol) N- bromosuccinimide (NBS) and 5 ml of absolute pyridine was stirred for 8 hours at 75°C (bath temperature). The resulting mixture was diluted with 50 ml of AcOEt and then 3 times washed with 10 ml of water. The organic phase was dried over sodium sulphate and the solvent removed in a water jet vacuum. The resulting crude material was purified by flash chromatography over silica gel (eluant: ethylacetate/heptanes 1 : 1). 237mg of compound 2.41 was obtained in the form of a slightly brownish powder (m.p.: 124-126°C). </p><p id="p0108" num="0108">Example 3: 3-Difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid [2-(3,3-dimethylbut-1- vnyl)-5,6,7,8-tetrahvdro-4H-cyclohepta[b1thiophen-8-yl1 methoxy amide (Compound 2.47): In a sulfonation flask a mixture of 218 mg (0.5 mmol) of compound 2.41 , 124 mg (1.5 mmol)</p><p id="p0109" num="0109">3,3-dimethyl-1-butine, 8.7 mg Cu(l)l (0.046 mmol), 32 mg (0.046 mmol) of bis- (triphenylphosphine)-palladium dichloride and 30 ml of triethylamine was stirred for 16 hours at 70°C. Then the triethylamine was distilled off and the residue purified by flash </p><p id="p0110" num="0110"> chromatography over silcagel (eluant: ethylacetate/heptanes 1 :2). 160 mg of compound 2.47 was obtained in the form of a slightly brownish powder (m.p.: 1 14-1 16°C). </p><p id="p0111" num="0111">Table 1 : Compounds of formula I, wherein A is Ai_: ("Me" signifies the methyl group) 
<img id="imgf000015_0001" he="16" wi="166" file="imgf000015_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="yes"/>
 
<!-- EPO <DP n="16"/>-->
</p><p id="p0112" num="0112"><img id="imgf000016_0001" he="234" wi="166" file="imgf000016_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="17"/>--></p><p id="p0113" num="0113"><img id="imgf000017_0001" he="219" wi="166" file="imgf000017_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="18"/>--><img id="imgf000018_0001" he="237" wi="166" file="imgf000018_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="19"/>--></p><p id="p0114" num="0114"><img id="imgf000019_0001" he="241" wi="166" file="imgf000019_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="20"/>--><img id="imgf000020_0001" he="91" wi="166" file="imgf000020_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0115" num="0115"> Table 2: Compounds of formula I, wherein A is A?:
<img id="imgf000020_0002" he="121" wi="166" file="imgf000020_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="yes"/>
 
<!-- EPO <DP n="21"/>-->

<img id="imgf000021_0001" he="235" wi="166" file="imgf000021_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 
<!-- EPO <DP n="22"/>-->
</p><p id="p0116" num="0116"><img id="imgf000022_0001" he="242" wi="166" file="imgf000022_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="23"/>--></p><p id="p0117" num="0117"><img id="imgf000023_0001" he="234" wi="167" file="imgf000023_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/><!-- EPO <DP n="24"/>--><img id="imgf000024_0001" he="112" wi="166" file="imgf000024_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0118" num="0118">Table 3 : Characterising data: </p><p id="p0119" num="0119"> Table 3 shows selected melting point and selected NMR data for compounds of Table 1 to 2.</p><p id="p0120" num="0120">CDCI<sub>3</sub> is used as the solvent for NMR measurements, unless otherwise stated. If a mixture of solvents is present, this is indicated as, for example: CDCI<sub>3</sub>/d<sub>6</sub>-DMSO). No attempt is made to list all characterising data in all cases. </p><p id="p0121" num="0121"> In Table 3 and throughout the description that follows, temperatures are given in degrees Celsius; "NMR" means nuclear magnetic resonance spectrum; MS signifies mass spectrum;</p><p id="p0122" num="0122">"%" is percent by weight, unless corresponding concentrations are indicated in other units. The following abbreviations are used throughout this description: m.p. = melting point boiling point, </p><p id="p0123" num="0123"> S = singlet broad </p><p id="p0124" num="0124"> d = doublet doublet of doublets </p><p id="p0125" num="0125"> t = triplet quartet </p><p id="p0126" num="0126"> m = multiplet parts per million </p><p id="p0127" num="0127"> Method for GC-MS 
<!-- EPO <DP n="25"/>-->
 Volatile CI/EI </p><p id="p0128" num="0128"> Mass spectra were obtained with GC-MS was conducted on a Thermo, MS: DSQ and GC: TRACE GC ULTRA with a column from Zebron phenomenex: Phase ZB-5ms 15 m, diam: 0.25 mm, 0.25 μητι, H<sub>2</sub> flow 1.7 mL/min, temp injector: 250°C, temp detector: 220°C, method: hold 2 min at 40 °C, 25°C/min until 320°C, hold 1 min12s at 320°C, total time 15min. All other reagents and solvents, unless otherwise noted, were purchased from commercial vendors and used without further purification. </p><p id="p0129" num="0129"> Method for LC-MS </p><p id="p0130" num="0130"> Method C </p><p id="p0131" num="0131"><img id="imgf000025_0001" he="109" wi="152" file="imgf000025_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="no"/></p><p id="p0132" num="0132">Table 3: </p><p id="p0133" num="0133">Cpd 1 H-NMR data: ppm MS [M+H]<sup>+</sup> m.p. LCMS data</p><p id="p0134" num="0134">No. (multiplicity/number of Hs) ZMD (°C) </p><p id="p0135" num="0135"> 1.1 128-130 </p><p id="p0136" num="0136"> 1.2 147-149 </p><p id="p0137" num="0137"> 1.4 93-98 </p><p id="p0138" num="0138"> 1.5 136-140 </p><p id="p0139" num="0139"> 1.34 123-125 
<!-- EPO <DP n="26"/>-->
 Cpd 1 H-NMR data: ppm MS [M+H]<sup>+</sup> m.p. LCMS data</p><p id="p0140" num="0140">No. (multiplicity/number of Hs) ZMD (°C) </p><p id="p0141" num="0141"> 1.35 146-139 </p><p id="p0142" num="0142"> 1.37 11 1-113 </p><p id="p0143" num="0143"> 1.40 126-128 </p><p id="p0144" num="0144"> 1.41 118-120 </p><p id="p0145" num="0145"> 1.46 97-99 </p><p id="p0146" num="0146"> 1.47 121-125 </p><p id="p0147" num="0147"> 1.49 resin </p><p id="p0148" num="0148"> 1.50 117-119 </p><p id="p0149" num="0149"> 1.55 resin </p><p id="p0150" num="0150"> 1.56 11 1-114 </p><p id="p0151" num="0151"> 2.34 138-140 </p><p id="p0152" num="0152"> 2.35 130-132 </p><p id="p0153" num="0153"> 2.37 115-117 </p><p id="p0154" num="0154"> 2.38 113-115 </p><p id="p0155" num="0155"> 2.40 114-117 </p><p id="p0156" num="0156"> 2.41 124-126 </p><p id="p0157" num="0157"> 2.46 136-138 </p><p id="p0158" num="0158"> 2.47 114-116 </p><p id="p0159" num="0159"> 2.50 resin </p><p id="p0160" num="0160"> 2.55 137-139 </p><p id="p0161" num="0161"> 2.56 112-115 </p><p id="p0162" num="0162"> Formulation examples for compounds of formula I: Example F-1.1 to F-1.2: Emulsifiable concentrates </p><p id="p0163" num="0163">Components F-1.1 F-1.2 compound of Tables 1-2 </p><p id="p0164" num="0164"> calcium dodecylbenzenesulfonate </p><p id="p0165" num="0165"> castor oil polyethylene glycol ether </p><p id="p0166" num="0166"> (36 mol ethylenoxy units) </p><p id="p0167" num="0167"> tnbutylphenolpolyethylene glycol ether </p><p id="p0168" num="0168"> (30 mol ethylenoxy units) 
<!-- EPO <DP n="27"/>-->
 Emulsions of any desired concentration can be prepared by diluting such concentrates with water. </p><p id="p0169" num="0169">Example F-2: Emulsifiable concentrate </p><p id="p0170" num="0170">Components F-2 compound of Tables 1-2 10% </p><p id="p0171" num="0171">octylphenolpolyethylene glycol ether </p><p id="p0172" num="0172"> (4 to 5 mol ethylenoxy units) 3% </p><p id="p0173" num="0173">calcium dodecylbenzenesulfonate 3% </p><p id="p0174" num="0174">castor oil polyglycol ether </p><p id="p0175" num="0175"> (36 mol ethylenoxy units) 4% </p><p id="p0176" num="0176">cyclohexanone 30% </p><p id="p0177" num="0177">xylene mixture 50% </p><p id="p0178" num="0178">Emulsions of any desired concentration can be prepared by diluting such concentrates with water. </p><p id="p0179" num="0179">Examples F-3.1 to F-3.4: Solutions </p><p id="p0180" num="0180">Components F-3.1 F-3.2 F-3.3 F-3.4 compound of Tables 1-2 80% </p><p id="p0181" num="0181">propylene glycol monomethyl ether 20% </p><p id="p0182" num="0182">polyethylene glycol (relative molecular </p><p id="p0183" num="0183">mass: 400 atomic mass units) </p><p id="p0184" num="0184"> N-methylpyrrolid-2-one </p><p id="p0185" num="0185">epoxidised coconut oil </p><p id="p0186" num="0186">benzin (boiling range: 160-190°) </p><p id="p0187" num="0187">The solutions are suitable for use in the form of microdrops. 
<!-- EPO <DP n="28"/>-->
 Examples F-4.1 to F-4.4: Granulates </p><p id="p0188" num="0188">Components F-4.1 F-4.2 F-4.3 F-4.4 compound of Tables 1-2 5% 10% 8% 21 % kaolin 94% - 79% 54% highly dispersed silicic acid 1 % - 13% 7% attapulgite - 90% - 18% </p><p id="p0189" num="0189">The novel compound is dissolved in dichloromethane, the solution is sprayed onto the carrier and the solvent is then removed by distillation under vacuum. </p><p id="p0190" num="0190">Examples F-5.1 and F-5.2: Dusts </p><p id="p0191" num="0191">Components F-5.1 F-5.2 compound of Tables 1-2 2% 5% </p><p id="p0192" num="0192">highly dispersed silicic acid 1 % 5% </p><p id="p0193" num="0193">talcum 97% - kaolin - 90% </p><p id="p0194" num="0194">Ready for use dusts are obtained by intimately mixing all components. Examples F-6.1 to F-6.3: Wettable powders </p><p id="p0195" num="0195">Components F-6.1 F-6.2 F-6.3 compound of Tables 1-2 25% 50% 75% </p><p id="p0196" num="0196">sodium lignin sulfonate 5% 5% </p><p id="p0197" num="0197">sodium lauryl sulfate 3% 5% </p><p id="p0198" num="0198">sodium diisobutylnaphthalene sulfonate 6% 10% </p><p id="p0199" num="0199">octylphenolpolyethylene glycol ether </p><p id="p0200" num="0200">(7 to 8 mol ethylenoxy units) 2% </p><p id="p0201" num="0201">highly dispersed silicic acid 5% 10% 10% </p><p id="p0202" num="0202">kaolin 62% 27% 
<!-- EPO <DP n="29"/>-->
 All components are mixed and the mixture is thoroughly ground in a suitable mill to give wettable powders which can be diluted with water to suspensions of any desired </p><p id="p0203" num="0203">concentration. Example F7: Flowable concentrate for seed treatment </p><p id="p0204" num="0204">compound of Tables 1-2 40 % </p><p id="p0205" num="0205">propylene glycol 5 % </p><p id="p0206" num="0206">copolymer butanol PO/EO 2 % </p><p id="p0207" num="0207">tristyrenephenole with 10-20 moles EO 2 % </p><p id="p0208" num="0208">1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % </p><p id="p0209" num="0209">monoazo-pigment calcium salt 5 % </p><p id="p0210" num="0210"> Silicone oil (in the form of a 75 % emulsion in water) 0.2 % </p><p id="p0211" num="0211"> Water 45.3 % </p><p id="p0212" num="0212"> The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. </p><p id="p0213" num="0213">BIOLOGICAL EXAMPLES: FUNGICIDAL ACTION: </p><p id="p0214" num="0214">Example B-1 : Action against Plasmopara viticola I grape / leaf disc preventative (late blight): Grape vine leaf disks were placed on water agar in multiwell plates (24-well format) and sprayed with test solutions (200 ppm active ingredient). After drying, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed 7 dpi (days after inoculation) as preventive fungicidal activity. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.2 and 1.5 showed good activity in this test (≥ 50% inhibition). </p><p id="p0215" num="0215">Example B-2: Blumeria graminis f. sp. tritici (Erysiphe graminis f. sp. tritici) / wheat / leaf disc preventive (Powdery mildew on wheat): </p><p id="p0216" num="0216"> Wheat leaf segments were placed on agar in a multiwell plate (24-well format) and sprayed with test solutions (200 ppm active ingredient). After drying, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed 4 dpi (days after inoculation) as preventive fungicidal activity. The 
<!-- EPO <DP n="30"/>-->
 activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.5 and 1.35 showed very good activity in this test (≥ 70% inhibition). </p><p id="p0217" num="0217">Example B-3: Puccinia recondite I wheat / leaf disc preventative (Brown rust): </p><p id="p0218" num="0218">Wheat leaf segments were placed on agar in multiwell plates (24-well format) and sprayed with test solutions (200 ppm active ingredient). After drying, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed 8 dpi (days after inoculation) as preventive fungicidal activity. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40, 2.41 and 2.47 showed very good activity in this test (≥ 80% inhibition). </p><p id="p0219" num="0219">Example B-4: Puccinia recondite I wheat / leaf disc curative (Brown rust): </p><p id="p0220" num="0220">Wheat leaf segments were placed on agar in multiwell plates (24-well format). The leaf disks were then inoculated with a spore suspension of the fungus One day after inoculation the test solution was applied (200 ppm active ingredient). After appropriate incubation the activity of a compound was assessed 8 dpi (days after inoculation) as curative fungicidal activity.</p><p id="p0221" num="0221">The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40, 2.41 and 2.47 showed very good activity in this test (≥ 80% inhibition). </p><p id="p0222" num="0222">Example B-5: Pyrenophora teres I barley / leaf disc preventive (Net blotch): </p><p id="p0223" num="0223">Barley leaf segments were placed on agar in a multiwell plate (24-well format) and sprayed with test solutions (200 ppm active ingredient). After drying, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed 4 dpi (days after inoculation) as preventive fungicidal activity. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. Compounds No. 1.1 , 1.2, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40 and 2.41 showed very good activity in this test (≥ 80% inhibition). </p><p id="p0224" num="0224">Example B-6: Botryotinia fuckeliana (Botrytis cinerea) I liquid culture (Gray mould): 
<!-- EPO <DP n="31"/>-->
 Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth. After placing a (DMSO) solution of the test compounds (200 ppm active ingredient) into a microtiter plate (96-well format) the nutrient broth containing the fungal spores was added. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 3-4 days. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40 and 2.41 showed very good activity in this test (≥ 80% inhibition). </p><p id="p0225" num="0225">Example B-7: Mycosphaerella arachidis (Cercospora arachidicola) I liquid culture (early leaf spot): </p><p id="p0226" num="0226"> Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of the test compounds (200 ppm active ingredient) into a microtiter plate (96-well format) the nutrient broth containing the fungal spores was added. The test plates were incubated at 24 °C and the inhibition of growth was measured photometrically after 6-7 days. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40, 2.41 and 2.47 showed very good activity in this test (≥ 80% inhibition). </p><p id="p0227" num="0227">Example B-8: Mycosphaerella graminicola (Septoria tritici) I liquid culture (Septoria blotch): </p><p id="p0228" num="0228"> Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of the test compounds (200 ppm active ingredient) into a microtiter plate (96-well format) the nutrient broth containing the fungal spores was added. The test plates were incubated at 24 °C and the inhibition of growth was measured photometrically after 4 days. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40, 2.41 and 2.47 showed very good activity in this test (≥ 80% inhibition). Example B-9: Thanatephorus cucumeris (Rhizoctonia solani) I liquid culture (foot rot, damping-off): 
<!-- EPO <DP n="32"/>-->
 Mycelia fragments of a newly grown liquid culture of the fungus were directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of the test compounds into a microtiter plate (96-well format), the nutrient broth containing the fungal material was added. The test plates are incubated at 24°C and the inhibition of growth is determined photometrically 3-4 days after application. The activity of a compound was expressed as fungal growth inhibition (0 = no growth inhibition, ratings of 80 % to 99 % mean good to very good inhibition, 100 % = complete inhibition). Compounds No. 1.1 , 1.2, 1.4, 1.5, 1.35, 1.37, 1.40, 1.41 , 2.34, 2.37, 2.38, 2.40 and 2.41 showed very good activity in this test (≥ 80% inhibition). 
</p></description><claims mxw-id="PCLM44727327" ref-ucid="WO-2012113696-A1" lang="EN" load-source="patent-office"><claim-statement><!-- EPO <DP n="33"/>-->What is claimed is: </claim-statement><claim id="clm-0001" num="1"><claim-text>1. A compound of formula I </claim-text><claim-text> <img id="imgf000033_0001" he="32" wi="71" file="imgf000033_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text>wherein </claim-text><claim-text> Ri is CrC<sub>4</sub>alkyl, C C<sub>4</sub>haloalkyl or C C<sub>4</sub>alkoxy; </claim-text><claim-text> R<sub>2</sub> is CrC<sub>4</sub>alkyl; </claim-text><claim-text> R<sub>3</sub> is hydrogen or halogen; </claim-text><claim-text> R<sub>4</sub> is hydrogen, C C<sub>4</sub>alkyl or C C<sub>4</sub>halogenalkyl; </claim-text><claim-text> X is methine or nitrogen; </claim-text><claim-text> A is </claim-text><claim-text> <img id="imgf000033_0002" he="38" wi="80" file="imgf000033_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text>R<sub>5</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; </claim-text><claim-text>R<sub>6</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl, -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl or -≡-aryl; </claim-text><claim-text>and agrochemically acceptable salts/isomers/structural </claim-text><claim-text>isomers/stereoisomers/diastereoisomers/enantiomers/tautomers and N-oxides of those compounds. </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. A compound of formula I according to claim 1 , wherein </claim-text><claim-text> is difluoromethyl or trifluoromethyl; </claim-text><claim-text>R<sub>2</sub> is methyl; </claim-text><claim-text>R<sub>3</sub> is hydrogen; and <!-- EPO <DP n="34"/>--> R<sub>4</sub> is methyl. </claim-text></claim><claim id="clm-0003" num="3"><claim-text>3. A compound of formula I according to claim 1 , wherein </claim-text><claim-text>Ri is CrC<sub>4</sub>haloalkyl; </claim-text><claim-text> R<sub>2</sub> is Ci-C<sub>4</sub>alkyl; </claim-text><claim-text>R<sub>3</sub> is hydrogen; </claim-text><claim-text>R<sub>4</sub> is Ci-C<sub>4</sub>alkyl; </claim-text><claim-text> R<sub>5</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl or -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl; </claim-text><claim-text>X is methine or nitrogen; and </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. A compound of formula I according to claim 1 , wherein </claim-text><claim-text>Ri is Ci-C<sub>4</sub>haloalkyl; </claim-text><claim-text> R<sub>2</sub> is Ci-C<sub>4</sub>alkyl; </claim-text><claim-text>R<sub>3</sub> is hydrogen; </claim-text><claim-text>R<sub>4</sub> is Ci-C<sub>4</sub>alkyl; </claim-text><claim-text> R<sub>6</sub> is hydrogen, halogen, -≡-CrC<sub>6</sub>alkyl or -≡-C<sub>3</sub>-C<sub>7</sub>cycloalkyl; </claim-text><claim-text>X is methine or nitrogen; and </claim-text><claim-text>A is A<sub>2</sub>. </claim-text></claim><claim id="clm-0005" num="5"><claim-text>5. A compound of formula II </claim-text><claim-text> <img id="imgf000034_0001" he="21" wi="35" file="imgf000034_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text>wherein A is as defined under formula I in claim 1. </claim-text></claim><claim id="clm-0006" num="6"><claim-text>6. A method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a compound of formula I according to claim 1 or a composition, comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof. </claim-text></claim><claim id="clm-0007" num="7"><claim-text>7. A composition for controlling and protecting against phytopathogenic microorganisms, comprising a compound of formula I according to claim 1 and at least one auxiliary. </claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
